12 views 0 likes

Dr. Todd Ponsky

Pediatric Surgery · View profile →

Biliary Atresia: Where are we now? Advanced Practice Providers Pediatric...

Video Published 2019-01-11 Updated 2022-08-22

Timestops (3)

Topic Overview

A clinical discussion of biliary atresia (BA) diagnosis and management, covering the pathophysiology of conjugated hyperbilirubinemia, diagnostic workup including ultrasound and HIDA scanning, the Kasai portoenterostomy procedure, and postoperative care. Key clinical points include the critical importance of early diagnosis (ideally before 8 weeks of age), the diagnostic challenge of identifying acholic stools and jaundice in non-Caucasian infants, and the lack of proven benefit for postoperative corticosteroids based on the BARC trial. The discussion addresses institutional variation in antibiotic prophylaxis protocols and the role of multidisciplinary follow-up with pediatric gastroenterology.

Key Takeaways

  • Conjugated/direct bilirubin ≥2 mg/dL requires urgent hepatology referral—biliary atresia is lethal if untreated.
  • Stool color is critical: acholic (pale/clay) stools in a jaundiced infant suggest biliary obstruction.
  • Biliary atresia incidence varies by ethnicity (1:5000 in Taiwan vs 1:18,000 in US/Europe); females more affected.
  • Normal ultrasound does NOT rule out biliary atresia—proceed to HIDA scan and liver biopsy if clinical suspicion high.
  • Kasai portoenterostomy outcomes improve dramatically when performed before 60 days of age—early diagnosis is critical.

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Kat — guest
  • Speaker 2 — host
  • Dr. Anselmo — guest
  • Laurie — guest
  • Speaker 5 — guest

Chapters

  • 0:00Introduction and Liver Physiology — Opening remarks and review of liver function, bilirubin metabolism, and the distinction between conjugated and unconjugated hyperbilirubinemia in neonatal jaundice.
  • 6:10Biliary Atresia Etiology and Diagnosis — Definition of biliary atresia as progressive obliterative cholangiopathy, epidemiology, suspected etiologies, and diagnostic approach including laboratory testing, imaging, and liver biopsy.
  • 11:02Surgical Management and Institutional Variation — Discussion of the Kasai portoenterostomy procedure, timing considerations, institutional variation in preoperative liver biopsy practices, and the impact of surgical volume on outcomes.
  • 19:32Postoperative Management and Outcomes — Postoperative antibiotic protocols, vitamin supplementation, monitoring strategies, and discussion of survival with native liver versus progression to transplant.
  • 26:40Case Study and Diagnostic Challenges — Presentation of case study examining timing of jaundice evaluation, identification of acholic stools, interpretation of HIDA scans, and racial disparities in diagnosis.
  • 38:19Corticosteroid Therapy and Future Directions — Review of evidence on postoperative corticosteroids including BARC trial results, discussion of IVIG as investigational therapy, and summary of key clinical points.

Key claims

  • 1:06Newborns produce a lot more bilirubin than adults — Kat
  • 2:24Pathologic jaundice occurs 1 in 2500 live births — Kat
  • 5:01Biliary atresia is a progressive, obliterative, idiopathic cholangiopathy — Kat
  • 5:12About 80% to 90% of babies present with perinatal or postnatal form versus 10 to 20% with a fetal or embryonic form — Kat
  • 5:42The incidence ranges from 1 in 5000 in some Asian countries like Taiwan, about 1 in 8 to 10,000 in Japan, and 1 to 18,000 in the United States and Europe — Kat
  • 6:05More females than males are affected by biliary atresia — Kat
  • 6:09There tends to be some seasonal clustering, which leads some to suspect that viruses or some sort of infectious process is a trigger for biliary atresia — Kat
  • 6:10Biliary atresia is lethal if untreated — Kat
  • 7:59If conjugated or direct bilirubin is greater than or equal to 2, the child needs to be evaluated more closely — Kat
  • 8:16There are babies with biliary atresia whose ultrasounds are normal — Kat
  • 8:26The gold standard for diagnosis is the intraoperative cholangiogram — Kat
  • 9:31At Children's Hospital, they pre-treat babies for 5 days of phenobarbital before the HIDA scan — Kat
  • 15:05Timing of the diagnosis and moving to the Kasai is extremely important, with the sweet spot being 6 to 8 weeks of age — Kat
  • 15:50A French study showed that 23% of their Kasai patients had their native liver 20 years post Kasai — Kat
  • 16:48In England, they increased their success with Kasai by consolidating to 3 centers performing their Kasai procedures — Kat
  • 17:20At Children's Hospital, they see 6 to 12 biliary atresia babies a year and are considered a high rate center — Kat
  • 20:08If cirrhosis is seen on liver biopsy or frozen section during intraoperative cholangiogram, they close up and proceed to transplant rather than Kasai — Kat
  • 21:10Getting babies to an older age for transplant through Kasai seems easier for transplant, despite some complications — Kat
  • 22:27Children's Hospital has a very large, if not the largest, living donor liver transplant center in the country — Kat
  • 24:06Most patients are put on peripheral lines rather than Broviacs for postoperative antibiotics — Kat
  • 25:08At Children's Hospital, babies only get intravenous antibiotics until they're taking orals, then switch to Bactrim — Kat
  • 25:17For babies less than 6 weeks of age, they use amoxicillin and then switch to Bactrim once they're 6 weeks of age or older — Kat
  • 25:28Bactrim is used at 4 to 5 mg per kg per day — Kat
  • 25:35Babies are put on ursodeoxycholic acid twice a day — Kat
  • 25:41These babies are fat soluble vitamin deficient, especially vitamin D, E, and K, and are supplemented with aqueous solutions like Aquadek or ADeck — Kat
  • 27:22The BARC protocol enrolled 140 babies into a randomized double-blind placebo-controlled study with steroids — Kat
  • 28:15Whenever a baby that's had a Kasai has an unexplained fever, ascending cholangitis is suspected — Kat
  • 29:36The more times a baby has an episode of ascending cholangitis, it does further damage the liver and may lead to an earlier need for transplant — Kat
  • 31:09Biliary atresia is the most common indication for pediatric liver transplant — Kat
  • 32:54The American Academy of Pediatrics policy statement says all jaundiced infants at 2 weeks of age should have a fractionated bilirubin done — Kat
  • 34:24In England, Caucasian babies' average age of diagnosis with biliary atresia was at 47 days of age, while non-white babies was 52 days of age — Kat
  • 34:44Any baby diagnosed after 100 days of age was only non-Caucasian — Kat
  • 36:05In an England study, 37% of physicians and nurses did not correctly identify a suspect stool using stool color cards — Kat
  • 38:41The 140 babies randomized between steroids and placebo in the BARC trial did not show any benefit from steroid use — Kat
  • 38:53Steroids did not improve outcomes with native liver survival — Kat
  • 39:02Studies found a more rapid drop in bilirubin level and increased jaundice clearance with steroids, but no one has found that steroids prevent or lengthen the time until a baby needs transplant — Kat
  • 40:29In the BARC trial, steroids were given for 14 weeks after the Kasai — Kat
  • 41:39In Taiwan and other Asian countries, they send stool cards home with every discharged baby — Kat
  • 42:32Children's Hospital will be a site using intravenous immunoglobulin following Kasai portoenterostomy in a new study — Kat
  • 44:47At Children's Hospital, surgeons like to see babies at the post-op two week check to ensure the incision is healing properly without infection — Kat
  • 45:03The GI department follows all biliary atresia babies after surgery at Children's Hospital — Kat
  • 47:40Bilirubin levels are obtained in the hospital before the baby leaves to see the trend — Kat

Cases discussed

  • 32:13Sandra, a 21-day-old female with persistent jaundice

Points of disagreement

  • 11:02Timing and method of liver biopsy
    • Speaker 2: Noted institutional variation - some centers do preoperative liver biopsy, others do it at time of cholangiogram
    • Dr. Anselmo: Does not always require a liver biopsy preoperatively if clinical picture is clear (acholic stools, jaundice, positive HIDA, absent gallbladder); asks for biopsy in unclear cases
  • 24:01Duration of postoperative IV antibiotics
    • Kat: At Children's Hospital, IV antibiotics only until taking orals, then switch to oral Bactrim
    • Laurie: Referenced a 2002 protocol using 10-12 weeks of IV antibiotics, noting that practice seems to be moving away from this
  • 19:32Whether to perform Kasai in older infants with cirrhosis
    • Dr. Anselmo: Questions whether Kasai is worth doing in a 3-3.5 month old with cirrhotic liver, or if should just list for transplant; concerned about creating ascites or increasing cholangitis risk
    • Kat: Has done Kasai in 3.5-4 month olds to bridge to transplant at older age, which may be easier for transplant despite complications
  • 38:19Use of postoperative corticosteroids
    • Dr. Anselmo: Believes the BARC trial data showing no benefit; last two Kasai cases did not use steroids and both drained well; would only consider for cholangitis or rescue
    • Speaker 2: Uses steroids in all patients but indicated might change practice after this discussion
  • 47:33Timing of postoperative bilirubin measurement
    • Kat: Gets bilirubin levels in hospital before baby leaves to see the trend
    • Dr. Anselmo: Does not care about immediate post-op bilirubin, wants to see stool color in diaper instead

Open questions

  • What is the etiology of biliary atresia - is it infectious, inflammatory, genetic, developmental, or environmental toxins?
  • Is the 14-week duration of steroids in the BARC trial long enough, or do babies need extended steroid therapy like asthmatics?
  • Should there be newborn screening for biliary atresia in the United States using stool cards as done in Taiwan?
  • Are there blood or urine tests that could be developed for early screening?
  • At what age or degree of cirrhosis should Kasai not be offered and proceed directly to transplant listing?
  • What is the optimal duration and route of postoperative antibiotic prophylaxis?
  • Will IVIG following Kasai portoenterostomy inhibit immune-mediated injury to bile ducts?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.
Written for:

Keywords

Hashtags

Transcript

Comments

Loading comments…